Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Peroxisome proliferator-activated receptor, Cancer research, Immunotherapy, Tumor progression, Agonist, and Cancer immunotherapy.
Dual function of activated PPARγ by ligands on tumor growth and immunotherapy
Regulation of cancer progression by CK2: an emerging therapeutic target
PPARγ agonist pioglitazone enhances colorectal cancer immunotherapy by inducing PD-L1 autophagic degradation
PPARγ agonist inhibits c‐Myc‐mediated colorectal cancer tumor immune escape
Role of ferroptosis on tumor progression and immunotherapy
CD47/SIRPα pathway mediates cancer immune escape and immunotherapy
AMPK phosphorylates PPARδ to mediate its stabilization, inhibit glucose and glutamine uptake and colon tumor growth
PD-L1 degradation pathway and immunotherapy for cancer
Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells
PPARδ agonist enhances colitis-associated colorectal cancer
Peroxisome proliferator-activated receptors (PPARs) are potential drug targets for cancer therapy
PPARδ promotes tumor progression via activation of Glut1 and SLC1-A5 transcription
PPARα induces cell apoptosis by destructing Bcl2
PPARδ Signaling Regulates Colorectal Cancer
EGFR/MDM2 signaling promotes NF-κB activation via PPARγ degradation